Hi glyco,I have also sold; maybe a bit too early. But at least I recovered my earlier loss. So, kind of back to square one ;-). Looking forward to re-entering.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
